Insmed Inc (INSM): Capital Expenditures
$32.56M
Year ended 2025-12-31
$28.75M
Trailing 12 months to 2026-06-30
+48.8%
3-year compound annual growth
+39.2%
5-year compound annual growth
+25.2%
10-year compound annual growth
| Period ended | Capital Expenditures | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $32.56M | +48.5% | 2026-02-19, From 2025-01-01 |
| 2024-12-31 | $21.92M | +65.0% | 2026-02-19, From 2024-01-01 |
| 2023-12-31 | $13.29M | +34.5% | 2026-02-19, From 2023-01-01 |
| 2022-12-31 | $9.88M | +35.5% | 2025-02-20, From 2022-01-01 |
| 2021-12-31 | $7.29M | +16.8% | 2024-02-22, From 2021-01-01 |
| 2020-12-31 | $6.24M | -85.2% | 2023-02-23, From 2020-01-01 |
| 2019-12-31 | $42.27M | +222.9% | 2022-02-17, From 2019-01-01 |
| 2018-12-31 | $13.09M | +336.2% | 2021-02-25, From 2018-01-01 |
| 2017-12-31 | $3.00M | -28.5% | 2020-02-25, From 2017-01-01 |
| 2016-12-31 | $4.20M | +21.6% | 2019-02-22, From 2016-01-01 |
| 2015-12-31 | $3.45M | -35.5% | 2018-02-23, From 2015-01-01 |
| 2014-12-31 | $5.35M | +547.8% | 2017-02-23, From 2014-01-01 |
| 2013-12-31 | $826.0K | +184.8% | 2016-02-25, From 2013-01-01 |
| 2012-12-31 | $290.0K | -70.4% | 2015-02-27, From 2012-01-01 |
| 2011-12-31 | $979.0K | n/a | 2014-03-06, From 2011-01-01 |
| 2010-12-31 | $0 | n/a | 2013-03-18, From 2010-01-01 |
| 2009-12-31 | $0 | n/a | 2012-03-13, From 2009-01-01 |
Capital Expenditures at similar companies
| Company | Year ended | Capital Expenditures | Change YoY |
|---|---|---|---|
| Insmed Inc (INSM) | 2025-12-31 | $32.56M | +48.5% |
| Opko Health, Inc. (OPK) | 2025-12-31 | $12.28M | -50.9% |
| TG Therapeutics, Inc. (TGTX) | 2025-12-31 | $214.0K | +375.6% |
| Axsome Therapeutics, Inc. (AXSM) | 2025-12-31 | $480.0K | +77.8% |
| Organogenesis Holdings Inc. (ORGO) | 2025-12-31 | $14.15M | +41.1% |
| HUTCHMED (China) Ltd (HCM) | 2025-12-31 | $14.15M | -21.1% |
| Ultragenyx Pharmaceutical Inc. (RARE) | 2025-12-31 | $6.00M | -14.3% |
| Kiniksa Pharmaceuticals International, plc (KNSA) | 2025-12-31 | $1.57M | +466.1% |
| Mirum Pharmaceuticals, Inc. (MIRM) | 2025-12-31 | $954.0K | -3.9% |
Compare INSM, OPK, TGTX, AXSM side by side · Screen every company in Pharmaceutical Preparations ↗